Cita APA

Villamañán de Santiago, L. (2019). Unraveling CK2 inhibition and temozolomide contribution to therapy response in preclinical GL261 glioblastoma: Immune system implications and magnetic resonance based nosological imaging.

Citación estilo Chicago

Villamañán de Santiago, Lucía|||0000-0002-6702-2103. Unraveling CK2 Inhibition and Temozolomide Contribution to Therapy Response in Preclinical GL261 Glioblastoma: Immune System Implications and Magnetic Resonance Based Nosological Imaging. 2019.

Cita MLA

Villamañán de Santiago, Lucía|||0000-0002-6702-2103. Unraveling CK2 Inhibition and Temozolomide Contribution to Therapy Response in Preclinical GL261 Glioblastoma: Immune System Implications and Magnetic Resonance Based Nosological Imaging. 2019.